Journals / Göğüs Kalp Damar Anestezi ve Yoğun Bakım Derneği Dergisi / 2022 / Cilt: 28 - Sayı: 2

Evaluation of the Effect of Del Nido and Cold Blood Cardioplegia on Renal Functions in the Surgery of Congenital Heart Diseases

Konjenital Kalp Hastalıkları Cerrahisinde Del Nido ve Soğuk Kan KardiyoplejisininBöbrek Fonksiyonlarına Etkisinin Değerlendirilmesi

Pages
135–143
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Cardiopulmonary bypass (CPB) duration (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We aimed to evaluate the effect of del Nido (DN) and cold blood (CB) cardioplegia on renal functions in children undergoing cardiac surgery for congenital heart disease (CHD).
📊
Key Findings & Data:One hundred and nineteen pediatric patients with Risk Adjustment for Congenital Heart Surgery (RACHS) scores below 3 were randomly assigned using allocation software to two groups (CB and DN cardioplegia) according to the type of cardioplegia solution used.
💡
Conclusion & Impact:Results: Cardiopulmonary bypass (CPB) duration (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We aimed to evaluate the effect of del Nido (DN) and cold blood (CB) cardioplegia on renal functions in children undergoing cardiac surgery for congenital heart disease (CHD). Methods: This study was conducted prospectively. One hundred and nineteen pediatric patients with Risk Adjustment for Congenital Heart Surgery (RACHS) scores below 3 were randomly assigned using allocation software to two groups (CB and DN cardioplegia) according to the type of cardioplegia solution used. The change of urea, creatinine, estimated glomerular filtration rate (eGFR), and renal near-infrared spectroscopy (NIRS) values before and after cardioplegia were the primary outcome measures of this study. Results: Cardiopulmonary bypass (CPB) duration (p

Özet

Amaç: Çalışmada, konjenital kalp hastalığı nedeniyle kalp cerrahisi geçiren çocuklarda del Nido ve soğuk kan kardiyoplejisinin böbrek fonksiyonlarına etkisinin değerlendirilmesi amaçlandı. Yöntem: Bu çalışma, prospektif olarak gerçekleştirildi. “Risk Adjustment for Congenital Heart Surgery (RACHS)” skoru 3’ün altında olan 119 pediatrik hasta, gruplandırma yazılımı kullanılarak kardiyopleji solüsyonunun tipine göre rastgele iki gruba (soğuk kan ve del Nido kardiyoplejisi) ayrıldı. Kardiyoplejiden önce ve sonra üre, kreatinin, tahmini glomerüler filtrasyon hızı ve renal yakın kızılötesi spektroskopi değerlerinin değişimi bu çalışmanın birincil sonuç ölçütleriydi. Bulgular: Del Nido grubunda kardiyopulmoner baypas süresi (p

🔖

Cite This Article

IŞILDAK, F. U., ARISÜT, S., YAVUZ, Y., YILMAZ, A. A. (2022). Evaluation of the Effect of Del Nido and Cold Blood Cardioplegia on Renal Functions in the Surgery of Congenital Heart Diseases. Göğüs Kalp Damar Anestezi ve Yoğun Bakım Derneği Dergisi, Cilt: 28 - Sayı: 2, 135–143. https://ajindex.com/articles/525911

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wu W, He J, Shao X. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990- 2017. Medicine (Baltimore) 2020;99:e20593
  2. Matte GS, del Nido PJ. History and use of del Nido cardioplegia solution at Boston Children's Hospital. J Extra Corpor Technol 2012;44:98–103
  3. Caneo LF, Matte GS, R Turquetto AL, Pegollo LMC, Amato Miglioli MC, T de Souza G, et al. Initial experience with del nido cardioplegia solution at a pediatric and congenital cardiac surgery program in Brazil. Perfusion 2021:2676591211020471
  4. Sanetra K, Pawlak I, Cisowski M. Del Nido cardioplegia - what is the current evidence? Kardiochir Torakochirurgia Pol 2018;15:114–8
  5. Ad N, Holmes SD, Massimiano PS, Rongione AJ, Fornaresio LM, Fitzgerald D. The use of del Nido cardioplegia in adult cardiac surgery: A prospective randomized trial. J Thorac Cardiovasc Surg 2018;155:1011–8
  6. Yerebakan H, Sorabella RA, Najjar M, Castillero E, Mongero L, Beck J, et al. Del Nido Cardioplegia can be safely administered in highrisk coronary artery bypass grafting surgery after acute myocardial infarction: A propensity matched comparison. J Cardiothorac Surg 2014;9:141
  7. Timek T, Willekes C, Hulme O, Himelhoch B, Nadeau D, Borgman A, et al. Propensity matched analysis of del nido cardioplegia in adult coronary artery bypass grafting: Initial experience with 100 consecutive patients. Ann Thorac Surg 2016;101:2237–41
  8. Smigla G, Jaquiss R, Walczak R, Bonadonna D, Kaemmer D, Schwimer C, et al. Assessing the safety of del Nido cardioplegia solution in adult congenital cases. Perfusion 2014;29:554–8
  9. Ota T, Yerebakan H, Neely RC, Mongero L, George I, Takayama H, et al. Short-term outcomes in adult cardiac surgery in the use of del Nido cardioplegia solution. Perfusion 2016;31:27–33
  10. Mick SL, Robich MP, Houghtaling PL, Gillinov AM, Soltesz EG, Johnston DR, et al. del Nido versus Buckberg cardioplegia in adult isolated valve surgery. J Thorac Cardiovasc Surg 2015;149:626–36
  11. Guajardo Salinas GE, Nutt R, Rodriguez-Araujo G. Del Nido cardioplegia in low risk adults undergoing first time coronary artery bypass surgery. Perfusion 2017;32:68–73
  12. Sorabella RA, Akashi H, Yerebakan H, Najjar M, Mannan A, Williams MR, et al. Myocardial protection using del nido cardioplegia solution in adult reoperative aortic valve surgery. J Card Surg 2014;29:445–9
  13. Charette K, Gerrah R, Quaegebeur J, Chen J, Riley D, Mongero L, et al. Single dose myo